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3ABSTRACT
From the trends of human immunodeficiency virus (HIV) epidemics in South and
Southeast Asia, it was postulated that an HIV epidemic would start as a blood-
borne infection among injecting drug users in the Philippines. In 2002, 560
individuals were recruited in Metro Cebu, Philippines and tested for HIV, hepatitis
C virus (HCV) and hepatitis B virus (HBV) infections. Seroprevalence of anti-HCV
among injecting drug users (70.1%, 61/87) was significantly higher than those
among inhalation drug users (16.3%, 7/43; P=0.00; OR=12), sex workers (0%,
0/130; P=0.00; OR=∞), antenatal clinic attendees (0%, 0/100; P=0.00; OR=∞), and
students/health care workers (2.0%, 4/200; P=0.00; OR=115). Seroprevalence of
HBsAg among injecting drug users (10.3%, 9/87) was significantly higher than
those among sex workers (2.3%, 3/130; P=0.01; OR=4.9), and antenatal clinic
attendees (3%, 3/100; P= 0.04; OR=3.7), but was not statistically different from
those among inhalation drug users (9.3%, 4/43; P=0.9) and students/health care
workers (4.5%, 9/200; P=0.06). None of the study population was reactive to
anti-HIV antibody. The HCV strains obtained from the injecting drug users
belonged to either genotype 1a or 2b and the strains in each genotype clustered
closely to each other. There was no dual infection with genotype 1a and 2b. These
suggest that the HCV infection in injecting drug users may be rapidly emanating
from limited source individuals in Metro Cebu, Philippines.
4INTRODUCTION
The Philippines is one of the low prevalence countries for human
immunodeficiency virus (HIV). Based on the AIDS registry of the Department of
Health in the Philippines, the total number of HIV cases has increased but
remained at low level at a cumulative total of 2,107 as of June 2004. Main mode of
HIV transmission has been reported to be heterosexual contact since 1984.
Although HIV-positive cases have appeared sporadically among sexually active
populations such as sex workers, no outbreak has occurred among them in this
country. However, wide-range HIV strains have already been introduced in the
country, i.e.; five HIV-1 subtypes (A, B, C, D, F), a circulating recombinant form
(CRF01_AE) [Espantaleon et al., 2003; Paladin et al., 1998; Santiago et al., 1998], a
recombinant strain (gag-A/env-B) [Espantaleon et al., 2003]. Even HIV-2 [Leano et
al., 2003] have been identified. Among these, HIV-1 subtype B was the most
predominant, followed by CRF01_AE [Paladin et al., 1998; Santiago et al., 1998;
Espantaleon et al., 2003]. The low prevalence and the variety of HIV strains in the
Philippines indicate that HIV has mainly been imported from abroad and the
gateway of HIV into the Philippines has been quite open. Therefore, the migration
sites and the subsequent circulation pathways of HIV have become one of the most
important concerns for the prevention of an AIDS outbreak in the Philippines.
The past trend of HIV/AIDS outbreak in South and Southeast Asia reported by
World Health Organization (WHO; HIV/AIDS in Asia and the Pacific Region 2003)
and others [Ruxrungtham et al., 2004] have implied that the Asian AIDS epidemic
may start among injecting drug users with secondary new infections being evident
among sex workers. This is reasonable when considering the fact that the
probability of HIV infection is 10-fold higher for the transmission through
5contaminated needle sharing than that through sexual contact [Royce et al., 1997].
Therefore, it could be postulated that an HIV outbreak would start as a blood-
borne infection among injecting drug users in the low HIV-prevalence countries
including the Philippines, and that the HIV outbreak could be preceded by other
blood-borne infections, such as hepatitis C virus (HCV) and hepatitis B virus (HBV)
infections.
HIV, HCV and HBV are the major blood-borne pathogens spreading among
injecting drug users via shared syringes and other injection devices [Lauer and
Walker, 2001]. Seroprevalence of HCV antibody (anti-HCV) has been globally
reported to be 65-90% among injecting drug users [Chamot et al., 1992; Crofts et
al., 1993; Lauer and Walker, 2001; Soriano et al., 2002; Van Ameijden et al., 1993;
van den Hoek et al., 1990] and 82.9-100% among HIV-infected injecting drug
users [van Asten et al., 2004]. However, the reports on the prevalence and the
characteristics of HCV and HBV have been limited in the Philippines. According to
the available data, the positive rate for anti-HCV was 2.2% (9/392 tested) and the
same rate was also noted for HBsAg among blood donors in 1990 [Arguillas et al.,
1991], and anti-HCV was reported to be 4.6% (23/502 tested) among inmates
[Katayama et al., 1996].
In this study, an HCV-epidemic site was identified in the Philippines and the
genetic links of the HCV strains infecting injecting drug users were analyzed to
determine their migration site, circulation pathways and the spreading speed.
6MATERIALS AND METHODS
Subjects
From June to August 2002, 560 individuals were recruited in Metro Cebu of
the Philippines. Study population was categorized into five groups; injecting drug
users (n=87), inhalation drug users (n=43), sex workers (n=130), antenatal clinic
attendees (n=100), and students and health care workers (n=200). Characteristics
of the study population are shown in Table I. Injecting drug users were from two
areas; an urban area where there was easy access to the prohibited drugs and the
drug rehabilitation centers where they were trying to be accustomed to be free
from the drugs. Injecting drug users were identified through the pre-tested
interview questionnaire conducted by a trained study staff. All of the 560
participants agreed to be part of the study after the researchers explained the
objectives and the conduct of the study, and signified their intent to join the study
by signing an informed consent form.
Serological testing
A total of 5 ml whole blood was collected from each participant. Plasma was
separated and subjected to each test.
Determine HIV-1/2 (ABBOTT JAPAN, Tokyo, Japan) and Determine HBsAg
(ABBOTT JAPAN) were used for the detection of anti-HIV antibody and Hepatitis B
surface antigen, respectively.  HCV PHA “ABBOTT” (ABBOTT HCV 2nd Generation)
was kindly provided by ABBOTT JAPAN for research purpose and was used for the
detection of anti-HCV in this study. All the systems were cautiously used
according to the manufacturer’s instructions.
RNA Extraction, Reverse Transcription and Polymerase Chain
Reaction (PCR)
7HCV-RNA was extracted from 100µl of plasma using SMITEST EX-R&D
(Genome Science Laboratories, Fukushima, Japan), and reverse-transcribed
according to First-Strand cDNA Synthesis protocol (Invitrogen, Carlsbad, CA) with
antisense gene-specific primers, hep32 (5’-GCDGARTACCTGGTCATAGC-3’) for
NS5B regions of HCV genome. A part of NS5B region of HCV gene was amplified by
nested PCR with primers, hep31b (5’-TGGGSTTCTCDTATGAYACC-3’)/hep32 in
the first round, and hep33b (5’-AYACCCGMTGYTTTGACTC-3’)/hep34b (5’-
CCTCCGTGAAKRCTCKCAG-3’) in the second round. Nested PCR was performed
with 20µl reaction mixture containing 2.5mM MgCl2, 200µM each dNTP, 0.5µM
primers and one unit of Amplitaq Gold® (Applied Biosystems, Foster City, CA).
First-round PCR was done with one cycle of 94ºC for 10 min, and 35 cycles of 94ºC
for 30 sec, 55ºC for 30 sec and 72ºC for 30 sec with a final extension of 72ºC for 10
min. Second-round PCR was done in the same condition except for the annealing
temperature at 60ºC. PCR amplification was confirmed by visualization with
ethidium bromide staining of the gel [White et al., 2000].
Genotyping
PCR product was subjected to nucleotide sequence determination directly
with the primers of hep33b and hep34b for NS5B region. Some of the PCR-
products were cloned with TOPO TA cloning kit (Invitrogen) and sequenced as
previously described [Thompson et al., 1994]. At least 11 clones per sample were
analyzed to investigate the possible co-existence of different HCV genotypes.
The sample sequences were aligned with HCV sequences from the database in
STD AIDS Cooperative Central Laboratory (Manila, the Philippines) and HCV
sequence database (http://gluttony.lanl.gov/content/hcv-db/combined_search/
search) by ClustalW with subsequent inspection and manual modification
[Thompson et al., 1994]. The frequency of nucleotide substitution in each base of
8the sequences was estimated by the Kimura two-parameter method. A
phylogenetic tree was constructed by the neighbor-joining method, and its
reliability was estimated by 1000 bootstrap replications. The profile of the tree
was visualized with the program of Njplot [Perriere and Gouy, 1996].
Statistical analysis
Prevalence data of HCV and HBV infection was analyzed by χ2 test and p value
less than 0.05 was considered to be significant.
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Prevalence of HCV, HBV and HIV infections
Of the 87 injecting drug users, 61 (70.1%) were positive for anti-HCV.
Twenty-eight of the injecting drug users were recruited from an area at the
downtown of Metro Cebu, and all of them (100%, 28/28) had anti-HCV. Of the 43
inhalation drug users, only seven (16.3%) had anti-HCV. No one was positive for
anti-HCV in the 130 sex workers and the 100 antenatal clinic attendees. Among
the students/health care workers (n=200), only 4 (2.0%) were positive for anti-
HCV (Table II). Thus, the prevalence of anti-HCV was significantly higher among
injecting drug users than inhalation drug users (P=0.00; Odds ratio (OR)=12, 95%
Confidence interval (CI): 5-31), sex workers (P=0.00; OR=∞), antenatal clinic
attendees (P=0.00; OR=∞), and students/health care workers (P=0.00; OR=115,
95% CI: 38-346), indicating that injecting drug use is significantly associated with
the HCV infection.
Seroprevalence of HBsAg among injecting drug users (10.3%, 9/87) was
significantly higher than that among sex workers (2.3%, 3/130; P=0.01; OR=5,
95% CI: 1-19) and antenatal clinic attendees (3.0%, 3/100; P= 0.04; OR=4, 95% CI:
1-14), but not than that among inhalation drug users (9.3%, 4/43; P=0.9) and
students/health care workers (4.5%, 9/200; P=0.06) (Table II).
HIV antibody was not detected in any of these groups (Table II).
Seven (8.0%) of the 87 injecting drug users were dually positive for HBsAg and
anti-HCV. Among other population groups, there was no dual positive case.
HCV Genotypes
Of the 61 injecting drug users positive for anti-HCV (Table II), 52 samples were
available for further analysis and 38 samples were positive for PCR with NS5B
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primers. Twenty-three of the PCR-positive samples were randomly selected and
were subjected to nucleotide sequencing. The PCR products were directly
sequenced and analyzed phylogenetically. A phylogenetic tree (Fig.1.) based on
NS5B sequences (nucleotides, 7975 to 8196 [Choo et al., 1991]) showed two HCV
genotypes, 1a and 2b. Of the 23 HCV strains analyzed, 15 clustered significantly
with genotype 1a reference sequences (with bootstrap value 97%), and most of
them sub-clustered together while two strains (02dx02 and 02du98) did not. The
remaining 8 clustered significantly with genotype 2b reference sequences and
formed a significant sub-cluster (with bootstrap value 96%), suggesting that the
source of HCV 2b circulation among the injecting drug users in Metro Cebu is
limited and 02du49 could be a founder strain (Fig.1.).
Heterogeneity of HCV strains in an injecting drug user
To investigate the possible co-existence of different HCV genotypes in an
injecting drug users, the PCR products of randomly selected 9 strains (5 genotype
1a strains: 02dz02, 02ccdm6, 02ccmk2, 02du98, 02qq01; and 4 genotype 2b
strains: 02ww8, 02ccdq4, 02ccdq5, 02du49) were cloned. At least 11 clones per
sample were sequenced in the regions of NS5B and analyzed phylogenetically.
Phylogenetic trees based on NS5B sequences showed that nucleotide sequences of
all the clones in each individual were homogeneous, and co-existence of genotype
1a and 2b were not observed.
11
DISCUSSION
In the current study, it was found that an HCV infection was epidemic in Metro
Cebu of the Philippines, where 70% of injecting drug users were positive for
anti-HCV. The prevalence of anti-HCV among injecting drug users has been
reported to be 65-90% globally [Chamot et al., 1992; Crofts et al., 1993; Van
Ameijden et al., 1993; van den Hoek et al., 1990], and that of Metro Cebu in our
study was consistent with the previous reports. Despite the high prevalence of
anti-HCV positive cases among the tested injecting drug users, HIV infection was
not observed at all.
Like most of RNA viruses, HCV exhibits genetic heterogeneity [Bukh et al., 1995;
Zuckerman and Zuckerman, 1995], which has been reported even within the same
individual [Chen et al., 1992; Higashi et al., 1993; Houghton et al., 1991; Martell et
al., 1992; Okamoto et al., 1991]. In our study, two HCV genotypes, 1a and 2b, were
circulating among injecting drug users in Metro Cebu, and each injecting drug
user had homogeneous HCV population regardless of the genotypes. These results
suggest that these HCV strains have been introduced recently into injecting drug
users in Metro Cebu and spreading rapidly among them from a few origins.
However, the origins have not been specified yet and further investigation is
required.
The rate of HBsAg was found to be from 2% to 10% among the different
population groups in Metro Cebu. However, there was no significant difference in
the seroprevalence of HBsAg between injecting drug users and inhalation drug
users (P= 0.85). This may be because newly acquired HBV results in acute
infection, needle sharing among injecting drug users may not contribute to the
increase in the HBV chronic infection, and HBV antigen carrier state may mainly
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be induced by vertical infections. For the further discussion, the detection of
anti-HBs antibody will be required.
The Philippines and Indonesia are both island countries and have similar
distances from Thailand and Cambodia where HIV infection is most prevalent in
Asia. By the year 1999, Indonesia had been considered to be one of the low and
slow HIV prevalence countries like the Philippines. However, in the late 2000,
sharp increase in HIV prevalence among injecting drug users (up to over 35% in
Jakarta) was noted (HIV/AIDS in Asia and the Pacific Region 2001, WHO). This
increasing trend of HIV prevalence was also noted among blood donors thereafter,
suggesting that the behavior of contaminated needle sharing (causing HCV
infection) triggered an AIDS outbreak before the increase in the number of HIV-
positives through sexual transmission. As seen in Indonesia, HIV spreads first
among injecting drug users, followed by sex workers in other Asian countries
especially if drug users are the clients of sex workers [Ruxrungtham et al., 2004].
However, it seems that HIV has not yet deeply migrated through the blood-borne
pathway in the Philippines. As shown in this study, HIV infection was very rare
even among HCV-positive injecting drug users. However, convincing evidence will
be given through the further analyses with increasing the number of subjects and
in geographically different places in the Philippines. Although HIV is of low
prevalence, the rapid spread of HCV infection indicates that the injecting drug
users can be at highest risk in causing an AIDS epidemic in this country.
In this study, it was demonstrated that the HCV infection clustered among
injecting drug users in Metro Cebu of the Philippines. HCV infection seemed to be
rapidly spreading among injecting drug users from limited sources. Further
studies must be conducted to specify the migration site(s) and the subsequent
circulation mode of HCV infection more precisely, which can serve as a model for
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probable migration sites of HIV infections at early phase of a possible AIDS
epidemic in the Philippines.
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TABLE I.  Characteristics of Injecting and Inhalation Drug Users and Others
Population Tested (Male/Female)  Mean Age (Range)
Injecting drug users  87 (80/7) 30 (13-46)
Inhalation drug users  43 (42/1) 29 (11-53)
Sex workers 130 (2/128) 25 (18-46)
Antenatal clinic attendees 100 (0/100) 26 (17-42)
Students/Health care workers 200 (65/135) 31 (6-61)
TABLE II.  Seroprevalence of Hepatitis B Virus, Hepatitis C Virus and HIV
Infections among Selected Population in Metro Cebu
Positive cases (%) for:
Population    Tested   HBsAg Anti-HCV Anti-HIV
Injecting drug users 87   9 (10%) 61 (70)   0
Downtown of Metro Cebua 28  3 (11) 28 (100)   0
Drug rehabilitation centers 59   6 (10) 33 ( 56)   0
Inhalation drug usersb 43  4 (9.3)  7 (16)   0
Sex workers 　 130   3 (2.3)  0   0
Antenatal clinic attendees 100   3 (3.0)  0   0
Students/Health care workers 200   9 (4.5)  4 (2.0)   0
a Clients from the downtown of Metro Cebu (n= 28) were all injecting drug users.  




Phylogenetic trees of 23 HCV strains (highlighted in the boxes) from injecting
drug users in Metro Cebu and 31 HCV strains from other area of the Philippines,
performed on 227 nt within the NS5B region by the neighbor-joining method with
GBV-B (accession no. NC 001655) as an outgroup. Analyzed samples were
indicated with two digits of the collecting year at the head of the ID (e.g. 02ES). If
the collecting year is unknown, IDs are shown with the symbol of “?” (e.g.?JF).
Accession numbers were used for the IDs of the genotype-known reference strains
with two digits indicating genotypes at the end of the number (e.g. L23471-5a).
Bootstrap values are given on the branches as percentage from 1,000 replicates.
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